Total Payments
$10,332
2024 Payments
$117.53
Companies
5
Transactions
39
Medicare Patients
962
Medicare Billing
$56,352
Payment Breakdown by Category
Consulting$6,870 (66.5%)
Travel$1,885 (18.2%)
Food & Beverage$1,211 (11.7%)
Other$365.60 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,870 | 2 | 66.5% |
| Travel and Lodging | $1,885 | 8 | 18.2% |
| Food and Beverage | $1,211 | 16 | 11.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $365.60 | 13 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $7,693 | 9 | $0 (2019) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,768 | 9 | $0 (2023) |
| Acorda Therapeutics, Inc | $365.60 | 13 | $0 (2018) |
| Biogen, Inc. | $338.59 | 4 | $0 (2024) |
| TG Therapeutics, Inc. | $167.59 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $117.53 | 3 | TG Therapeutics, Inc. ($60.48) |
| 2023 | $152.62 | 2 | Biogen, Inc. ($82.80) |
| 2022 | $107.11 | 2 | TG Therapeutics, Inc. ($107.11) |
| 2020 | $708.00 | 2 | Novartis Pharmaceuticals Corporation ($708.00) |
| 2019 | $7,843 | 10 | Celgene Corporation ($7,693) |
| 2018 | $1,239 | 18 | Novartis Pharmaceuticals Corporation ($873.06) |
| 2017 | $164.90 | 2 | Novartis Pharmaceuticals Corporation ($116.90) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $26.40 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 09/04/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $17.60 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 08/20/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $17.60 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 08/10/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $22.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 07/24/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $26.40 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 07/20/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $26.40 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 07/10/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $26.40 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 06/08/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $35.20 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 05/22/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $30.80 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 05/14/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $26.40 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 05/02/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $36.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 03/06/2018 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $48.74 | General |
| 11/16/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $116.90 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2017 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $48.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 218 | 254 | $66,000 | $14,371 |
| 2022 | 4 | 222 | 271 | $60,912 | $13,585 |
| 2021 | 9 | 275 | 313 | $62,959 | $14,814 |
| 2020 | 6 | 247 | 281 | $58,336 | $13,581 |
Total Patients
962
Total Services
1,119
Medicare Billing
$56,352
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 82 | $17,901 | $4,248 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 56 | $17,618 | $4,202 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 32 | 37 | $11,640 | $2,332 | 20.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $9,191 | $1,743 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 34 | 41 | $8,950 | $1,679 | 18.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 20 | $700.00 | $168.00 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 83 | $24,402 | $6,223 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 46 | 55 | $16,170 | $3,176 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 64 | $13,056 | $3,135 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 22 | 22 | $4,488 | $841.45 | 18.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 11 | 15 | $1,740 | $115.03 | 6.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 21 | 32 | $1,056 | $94.83 | 9.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 70 | $19,600 | $5,587 | 28.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 42 | 46 | $12,880 | $2,784 | 21.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 40 | $7,760 | $2,069 | 26.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 28 | 30 | $5,820 | $1,296 | 22.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 11 | 11 | $4,906 | $1,174 | 23.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 17 | 20 | $5,260 | $1,092 | 20.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 13 | 15 | $2,745 | $409.64 | 14.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 14 | 16 | $1,376 | $124.32 | 9.0% |
| 84460 | Liver enzyme (sgpt), level | Office | 2021 | 15 | 19 | $950.00 | $100.70 | 10.6% |
| 84450 | Liver enzyme (sgot), level | Office | 2021 | 14 | 18 | $738.00 | $93.24 | 12.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 24 | 28 | $924.00 | $84.00 | 9.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 49 | 61 | $16,226 | $3,273 | 20.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 40 | 44 | $9,936 | $3,190 | 32.1% |
About Dr. Christopher Luzzio, MD
Dr. Christopher Luzzio, MD is a Neurology healthcare provider based in Madison, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720051576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Luzzio, MD has received a total of $10,332 in payments from pharmaceutical and medical device companies, with $117.53 received in 2024. These payments were reported across 39 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($6,870).
As a Medicare-enrolled provider, Luzzio has provided services to 962 Medicare beneficiaries, totaling 1,119 services with total Medicare billing of $56,352. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Madison, WI
- Active Since 02/10/2006
- Last Updated 01/11/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1720051576
Products in Payments
- Ozanimod (Drug) $7,556
- ARZERRA (Drug) $873.06
- AMPYRA (Drug) $365.60
- TYSABRI (Biological) $150.00
- GILENYA (Drug) $116.90
- Tysabri (Biological) $82.80
- KESIMPTA (Drug) $69.82
- BRIUMVI (Drug) $60.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Madison
Michael Snyder, Md, MD
Neurology — Payments: $225,885
Neurology $225,885
Dr. Mary Zupanc, Md, MD
Neurology — Payments: $148,965
Neurology $148,965
Kenneth Mack, M.d, M.D
Neurology — Payments: $62,970
Neurology $62,970
Kelsey Gagesch, M.d, M.D
Neurology — Payments: $59,308
Neurology $59,308
Ali Zandieh, M.d, M.D
Neurology — Payments: $51,781
Neurology $51,781
Jennifer Kwon, Md, MD
Neurology — Payments: $39,152
Neurology $39,152